Literature DB >> 30302784

Power analysis for multivariable Cox regression models.

Emil Scosyrev1, Ekkehard Glimm2.   

Abstract

In power analysis for multivariable Cox regression models, variance of the estimated log-hazard ratio for the treatment effect is usually approximated by inverting the expected null information matrix. Because, in many typical power analysis settings, assumed true values of the hazard ratios are not necessarily close to unity, the accuracy of this approximation is not theoretically guaranteed. To address this problem, the null variance expression in power calculations can be replaced with one of the alternative expressions derived under the assumed true value of the hazard ratio for the treatment effect. This approach is explored analytically and by simulations in the present paper. We consider several alternative variance expressions and compare their performance to that of the traditional null variance expression. Theoretical analysis and simulations demonstrate that, whereas the null variance expression performs well in many nonnull settings, it can also be very inaccurate, substantially underestimating, or overestimating the true variance in a wide range of realistic scenarios, particularly those where the numbers of treated and control subjects are very different and the true hazard ratio is not close to one. The alternative variance expressions have much better theoretical properties, confirmed in simulations. The most accurate of these expressions has a relatively simple form. It is the sum of inverse expected event counts under treatment and under control scaled up by a variance inflation factor.
© 2018 John Wiley & Sons, Ltd.

Entities:  

Keywords:  Cox regression; power analysis; sample size

Mesh:

Year:  2018        PMID: 30302784     DOI: 10.1002/sim.7964

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  7 in total

1.  Alternative splicing patterns reveal prognostic indicator in muscle-invasive bladder cancer.

Authors:  BaiHeTiYa AZhaTi; Gaoliang Wu; Hailun Zhan; Wei Liang; Zhijian Song; Leilei Lu; Qichao Xie
Journal:  World J Surg Oncol       Date:  2022-07-12       Impact factor: 3.253

2.  Reevaluating the Evidence for Intensive Postoperative Extracolonic Surveillance for Nonmetastatic Colorectal Cancer.

Authors:  Jonah Popp; David S Weinberg; Eva Enns; John A Nyman; J Robert Beck; Karen M Kuntz
Journal:  Value Health       Date:  2021-10-13       Impact factor: 5.101

3.  Novel Insights Into Triple-Negative Breast Cancer Prognosis by Comprehensive Characterization of Aberrant Alternative Splicing.

Authors:  Shasha Gong; Zhijian Song; David Spezia-Lindner; Feilong Meng; Tingting Ruan; Guangzhi Ying; Changhong Lai; Qianqian Wu; Yong Liang
Journal:  Front Genet       Date:  2020-06-11       Impact factor: 4.599

4.  Lymph node ratio predicts overall survival in patients with stage II non-small cell lung cancer: a population-based SEER analysis.

Authors:  Nan Feng; Bo Wu; Xiang Zhang; Jianhui Chen; Zhongtian Xiang; Yiping Wei; Wenxiong Zhang
Journal:  Discov Oncol       Date:  2022-08-18

5.  Improving on-treatment risk stratification of cancer patients with refined response classification and integration of circulating tumor DNA kinetics.

Authors:  Jiawei Lv; Chenfei Wu; Junyan Li; Foping Chen; Shiwei He; Qingmei He; Guanqun Zhou; Jun Ma; Ying Sun; Denghui Wei; Li Lin
Journal:  BMC Med       Date:  2022-08-23       Impact factor: 11.150

6.  The association between plate location and hardware removal following ulna shortening osteotomy: a cohort study.

Authors:  Joris S Teunissen; Sanharib Al Shaer; Brigitte P A van der Heijden; Ruud W Selles; Steven E R Hovius; Oliver T Zöphel
Journal:  J Hand Surg Eur Vol       Date:  2022-04-11

7.  The Impact of Metabolic Syndrome and Lifestyle Habits on the Risk of the First Event of Cardiovascular Disease: Results from a Cohort Study in Lithuanian Urban Population.

Authors:  Vilma Jasiukaitienė; Dalia Lukšienė; Abdonas Tamošiūnas; Ričardas Radišauskas; Martin Bobak
Journal:  Medicina (Kaunas)       Date:  2020-01-03       Impact factor: 2.430

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.